Cargando…

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy

The feasibility and efficacy of hypofractionated salvage radiotherapy (HS-RT) for prostate cancer (PC) with biochemical recurrence (BR) after prostatectomy, and the usefulness of prostate-specific antigen (PSA) kinetics as a predictor of BR, were evaluated in 38 patients who received HS-RT without a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishikawa, Hitoshi, Higuchi, Keiko, Kaminuma, Takuya, Takezawa, Yutaka, Saito, Yoshitaka, Etsunaga, Toru, Maruo, Kazushi, Kawamura, Hidemasa, Kubo, Nobuteru, Nakano, Takashi, Kobayashi, Mikio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Oncology/Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674678/ https://www.ncbi.nlm.nih.gov/pubmed/32888035 http://dx.doi.org/10.1093/jrr/rraa074

Ejemplares similares

Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
por: Harada, Kosaku, et al.
Publicado: (2012)

Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study
por: Takakusagi, Yosuke, et al.
Publicado: (2019)

Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
por: Kawamura, Hidemasa, et al.
Publicado: (2020)

Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience
por: Murgic, Jure, et al.
Publicado: (2021)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
por: Quero, Laurent, et al.
Publicado: (2008)

What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?
por: Milecki, Piotr, et al.
Publicado: (2011)

Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
por: Wang, Yu-Jen, et al.
Publicado: (2016)

Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

Dosimetric comparison of carbon ion and X-ray radiotherapy for Stage IIIA non–small cell lung cancer
por: Kubo, Nobuteru, et al.
Publicado: (2016)

Radiotherapy for Epstein-Barr Virus-Positive Mucocutaneous Ulcer at the Lower Leg Skin: A Case Report
por: Kubo, Nobuteru, et al.
Publicado: (2022)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Salvage robotic radical prostatectomy
por: Kaffenberger, Samuel D., et al.
Publicado: (2014)

Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study
por: Mizowaki, Takashi, et al.
Publicado: (2015)

A Promising Treatment Strategy for Lung Cancer: A Combination of Radiotherapy and Immunotherapy
por: Miyasaka, Yuhei, et al.
Publicado: (2021)

Double-layer omics analysis of castration- and X-ray-resistant prostate cancer cells
por: Iwanaga, Mototaro, et al.
Publicado: (2022)

Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
por: Bluemel, Christina, et al.
Publicado: (2016)

Image Guided Hypofractionated Radiotherapy by Helical Tomotherapy for Prostate Carcinoma: Toxicity and Impact on Nadir PSA
por: Barra, Salvina, et al.
Publicado: (2014)

Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir
por: Anwar, Mekhail, et al.
Publicado: (2014)

Dose–volume constraints for head‐and‐neck cancer in carbon ion radiotherapy: A literature review
por: Varnava, Maria, et al.
Publicado: (2023)

The natural history of a delayed detectable PSA after radical prostatectomy
por: Szymaniak, Julie A., et al.
Publicado: (2023)

MRI response of obturator internus muscle to carbon-ion dose in prostate cancer treatment
por: Kawahara, Masahiro, et al.
Publicado: (2019)

Introduction of salvage prostatectomy in Denmark: the initial experience
por: Mortensen, Mike Allan, et al.
Publicado: (2022)

Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy
por: Jacinto, Alexandre A, et al.
Publicado: (2007)

Salvage radiotherapy after radical prostatectomy: outcomes and prognostic factors especially focusing on pathological findings
por: Hayashi, Satoko, et al.
Publicado: (2012)

Moderate hypofractionated radiotherapy after prostatectomy for cancer patients: toxicity and clinical outcome
por: Barra, Salvina, et al.
Publicado: (2018)

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome
por: Dubinsky, Pavol, et al.
Publicado: (2023)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
por: Asha, Wafa, et al.
Publicado: (2023)

Impact of Inter-fractional Anatomical Changes on Dose Distributions in Passive Carbon-Ion Radiotherapy for Prostate Cancer: Comparison of Vertical and Horizontal Fields
por: Yokoyama, Ayaka, et al.
Publicado: (2020)

Carbon ion radiotherapy for prostate cancer with bladder invasion
por: Miyasaka, Yuhei, et al.
Publicado: (2021)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

Three Months’ PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy—STARR (NCT05455736)
por: Francolini, Giulio, et al.
Publicado: (2023)

Technical caveats in salvage robot assisted radical prostatectomy
por: Tamhankar, Ashwin, et al.
Publicado: (2020)

Salvage Hypofractionated Radiotherapy in a Progressive Radiation-Induced Angiosarcoma: A Case Report
por: Bonzano, Elisabetta, et al.
Publicado: (2017)

Cyberknife(®) hypofractionated stereotactic radiosurgery (CK-hSRS) as salvage treatment for brain metastases
por: Telentschak, Sergej, et al.
Publicado: (2021)

Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial
por: Park, Geumju, et al.
Publicado: (2021)

A Japanese registry study and systematic review of particle therapy for renal cell carcinoma
por: Ishikawa, Hitoshi, et al.
Publicado: (2023)

Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
por: Kwon, Ohseong, et al.
Publicado: (2014)

Robotic Salvage Lymph Node Dissection After Radical Prostatectomy
por: Torricelli, Fabio C. M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gidop7uprtpk9tec5583kuaff3